Get started
Author

Brittany Morrow

ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
2022 · Rodney Cheng-En Hsieh, Sunil Krishnan, et al. · Science Immunology · 182
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
2019 · Matthew J. Reilley, Brittany Morrow, et al. · Journal for ImmunoTherapy of Cancer · 78
High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege
2021 · Casey R Ager, Akash Boda, et al. · Journal for ImmunoTherapy of Cancer · 76
PDF
592 ATR-mediated CD47 and PD-L1 upregulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
2021 · Rodney Cheng-En Hsieh, Sunil Krishnan, et al. · Regular and Young Investigator Award Abstracts · 9
PDF
Abstract 4213: Targeting the cMet inhibitors combined with anti-PD-1 therapy: Preclinical approach to turn the resistance into opportunities for overcoming tumor evasion
2022 · Ricardo Alexandre de Azevedo, Hsieh Cheng-En, et al. · Cancer Research · 2
622 Disrupted oxygen supply and tumor hyper- oxygen consumption contribute independently to prostate cancer immune privilege
2021 · Priyamvada Jayaprakash, Meghan Rice, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
RhoA Y42C drives cell plasticity and PD-1-mediated immune evasion of diffuse gastric cancer
2026 · Kyung-Pil Ko, Sangmin Kim, et al. · Nature Communications
PDF
705 Hypoxia-activated prodrugs with distinct mechanisms of action sensitize murine prostate tumors to immune checkpoint blockade
2024 · Priyamvada Jayaprakash, Krithikaa Rajkumar Bhanu, et al. · Regular and Young Investigator Award Abstracts
Abstract 5745: Proposing the best MET inhibitor to improve anti-PD-1 efficacy in HCC
2023 · Ricardo A. de Azevedo, Broderick Turner, et al. · Cancer Research
472 Knockdown of VISTA protein using antisense oligonucleotides promotes superior anti-tumor immunity compared to antibody blockade
2022 · Brittany Morrow, Michael Curran, et al. · Regular and Young Investigator Award Abstracts
PDF
831 Targeting tumor oxidative metabolism to overcome hypoxia-induced immunotherapy resistance in prostate cancer
2022 · Priyamvada Jayaprakash, Michael Curran, et al. · Regular and Young Investigator Award Abstracts
PDF
Abstract 4183: Differential modulation of tumor versus T cell oxidative phosphorylation potentiates anti-tumor immunity
2022 · Krithikaa Rajkumar Bhanu, Priyamvada Jayaprakash, et al. · Cancer Research
Correction: Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer
2021 · Michael A Curran, Casey R Ager, et al. · Journal for ImmunoTherapy of Cancer
Works count: 15
Citation count: 348
H-index: 4
I10-index: 3
Year
Topic
Type